Where The Human Leukocyte Antigen (HLA) Antibody Screening Market Is Headed With Insights On Size, Trends, And Opportunities

 The Business Research Company’s 2026 market reports incorporate enhanced features, including market attractiveness scoring and analysis, total addressable market evaluation, a company scoring matrix, an interactive Excel data dashboard, refined supply chain analysis, insights on emerging startups, and overviews of key products, all aimed at improving the depth, usability, and strategic relevance of the insights delivered.

What Market Size Is The Human Leukocyte Antigen (HLA) Antibody Screening Market Expected To Reach By 2030?
The human leukocyte antigen (HLA) antibody screening market size has grown strongly in recent years. It will grow from $0.98 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising number of organ transplant procedures, increasing incidence of end-stage organ failure, growing awareness of transplant rejection risks, expansion of transfusion medicine practices, technological advancements in immunoassay platforms.

The human leukocyte antigen (HLA) antibody screening market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for precision transplant matching, growing adoption of multiplex bead-based assays, rising investments in transplant immunology research, expansion of transplant programs in emerging markets, technological innovation in automated hla antibody screening systems. Major trends in the forecast period include increasing adoption of single antigen bead assays for enhanced sensitivity, rising demand for comprehensive pre-transplant immunological risk assessment, growing use of high-throughput flow cytometry in hla screening, expansion of post-transplant antibody monitoring protocols, increasing standardization of hla antibody detection methods.

Download Your Free Report Sample:
https://www.thebusinessresearchcompany.com/sample_request?id=12617629&type=smp&name=Human%20Leukocyte%20Antigen%20%28HLA%29%20Antibody%20Screening%20Market%20Report%202026

What Are The Major Drivers Supporting The Human Leukocyte Antigen (HLA) Antibody Screening Market Growth?
The rising organ transplantation rates are expected to propel the growth of the HLA antibody screening market going forward. Organ transplantation rates refer to the number of organ transplant procedures performed within a specific population and time, typically expressed per year or per million people. The rise in transplantation procedures is largely attributed to the increasing burden of chronic and end-stage diseases, as more patients advance to organ failure, the demand for organ replacement therapies correspondingly increases. HLA antibody screening supports higher organ transplantation success by ensuring better donor-recipient matching before surgery, thereby lowering the likelihood of immune-mediated rejection that reduces graft loss and complications, improving long-term transplant outcomes, and enabling more effective use of available donor organs. For instance, in January 2025, according to the Health Resources and Services Administration, a US-based Department of Health and Human Services agency, lung transplants experienced the highest proportional increase between 2023 and 2024, rising from 3,026 procedures to 3,340, which represents a 10.4% growth. Therefore, the rising organ transplantation rates are driving the growth of the HLA antibody screening market.

Which Companies Are Considered Industry Leaders In The Human Leukocyte Antigen (HLA) Antibody Screening Market?
The human leukocyte antigen (HLA) antibody screening market covered in this report is segmented –

1) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Luminex, Other Technologies
2) By Product Type: Reagents And Kits, Instruments, Software
3) By Target Class: Human Leukocyte Antigen Class I Antibodies, Human Leukocyte Antigen Class II Antibodies, Non- Human Leukocyte Antigen Antibodies
4) By Application: Pre-Transplant Screening, Post-Transplant Monitoring, Transfusion Medicine, Research Applications
5) By End-User: Hospitals And Transplant Centers, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:
1) By Enzyme Linked Immunosorbent Assay: Direct Enzyme Linked Immunosorbent Assay, Indirect Enzyme Linked Immunosorbent Assay, Sandwich Enzyme Linked Immunosorbent Assay, Competitive Enzyme Linked Immunosorbent Assay
2) By Flow Cytometry: Conventional Flow Cytometry, Bead Based Flow Cytometry, Imaging Flow Cytometry, High Throughput Flow Cytometry
3) By Luminex: Single Antigen Luminex Assay, Multi Antigen Luminex Assay, Bead Based Multiplex Luminex Assay, Custom Luminex Panels
4) By Other Technologies: Western Blotting, Radioimmunoassay, Complement Dependent Cytotoxicity Assay, Microarray Based Assay

What Market Trends Should Companies Track In The Human Leukocyte Antigen (HLA) Antibody Screening Market?
Major companies operating in the HLA antibody screening market are focusing on developing next-generation HLA research tools to improve immune checkpoint research, antibody validation, and assay development accuracy. Next-generation HLA research tools comprise innovative recombinant reagents, multiplexed analytical platforms, and high-resolution molecular technologies that allow accurate profiling of HLA molecules and their antibody interactions. For instance, in November 2025, HLA Protein Technologies, a US-based biotechnology company, launched its sHLA-G Monomer and Tetramer Portfolio, a next-generation HLA research tool that supports high-fidelity checkpoint biology studies, target validation, and assay development. The portfolio provides structurally validated recombinant HLA-G reagents optimized for immune receptor interaction studies, facilitating enhanced characterization of HLA-associated antibodies and advancing applications in transplant immunology, oncology, and immune tolerance research.

How Are Different Segments Organized Within The Human Leukocyte Antigen (HLA) Antibody Screening Market?
The human leukocyte antigen (HLA) antibody screening market covered in this report is segmented –

1) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Luminex, Other Technologies
2) By Product Type: Reagents And Kits, Instruments, Software
3) By Target Class: Human Leukocyte Antigen Class I Antibodies, Human Leukocyte Antigen Class II Antibodies, Non- Human Leukocyte Antigen Antibodies
4) By Application: Pre-Transplant Screening, Post-Transplant Monitoring, Transfusion Medicine, Research Applications
5) By End-User: Hospitals And Transplant Centers, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:
1) By Enzyme Linked Immunosorbent Assay: Direct Enzyme Linked Immunosorbent Assay, Indirect Enzyme Linked Immunosorbent Assay, Sandwich Enzyme Linked Immunosorbent Assay, Competitive Enzyme Linked Immunosorbent Assay
2) By Flow Cytometry: Conventional Flow Cytometry, Bead Based Flow Cytometry, Imaging Flow Cytometry, High Throughput Flow Cytometry
3) By Luminex: Single Antigen Luminex Assay, Multi Antigen Luminex Assay, Bead Based Multiplex Luminex Assay, Custom Luminex Panels
4) By Other Technologies: Western Blotting, Radioimmunoassay, Complement Dependent Cytotoxicity Assay, Microarray Based Assay

Explore the Complete Human Leukocyte Antigen (HLA) Antibody Screening Market Report:
https://www.thebusinessresearchcompany.com/report/human-leukocyte-antigen-hla-antibody-screening-market-report

Which Regions Are Projected To Grow At The Highest Rate In The Human Leukocyte Antigen (HLA) Antibody Screening Market?
North America was the largest region in the human leukocyte antigen (HLA) antibody screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human leukocyte antigen (HLA) antibody screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. How has the ammonia grown historically, and what trends indicate future expansion? The ammonia market size has grown strongly in recent years. It will grow from $79.13 billion in 2024 to $85.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to agricultural demand, expanding population, energy and power generation, chemical manufacturing:. The ammonia market size is expected to see strong growth in the next few years. It will grow to $124.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to hydrogen economy development, renewable energy, carbon capture and storage (ccs), clean energy transition. Major trends in the forecast period includ...
Read more

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the poultry disinfectant industry by 2029? The poultry disinfectant market size has grown strongly in recent years. It will grow from $4.67 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to demand for biosecurity and disease prevention, growth in poultry farming and agriculture, expansion of food safety regulations, use in hatcheries and broiler farms, regulatory standards for poultry hygiene. The poultry disinfectant market size is expected to see rapid growth in the next few years. It will grow to $7.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to sustainable and eco-frie...
Read more

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Ammonium Sulfate industry. What is the projected value of the ammonium sulfate market by 2029? The ammonium sulfate market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to economic growth, agriculture demand, government subsidies, population growth, rise in chemical industry. The ammonium sulfate market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing crop yields, environmental regulations, food security concerns, rising pharmaceuticals sector, rise in disposable income. Major ...
Read more